$1.82
+0.01 (+0.55%)
Open$1.78
Previous Close$1.81
Day High$1.92
Day Low$1.77
52W High$4.09
52W Low$1.56
Volume—
Avg Volume45.9K
Market Cap70.49M
P/E Ratio—
EPS$-0.65
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,762.1% upside
Current
$1.82
$1.82
Target
$33.89
$33.89
$29.33
$33.89 avg
$54.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 66.2K | 98.9K | 14.53M |
| Net Income | -26,087,497 | -35,074,316 | -1,603,701 |
| Profit Margin | -39,417.3% | -37,446.4% | -11.0% |
| EBITDA | -29,058,800 | -41,239,707 | -1,702,906 |
| Free Cash Flow | — | — | -884,905 |
| Rev Growth | -33.1% | -33.1% | +22.5% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |